Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person22
PAVmed Inc.
Company
INSMED Inc
Company
PAID INC
Company
IR-Med, Inc.
Company
MED-X, INC.
Company
RESMED INC
Company
PACCAR INC
Company
PTC INC.
Company
PAYCHEX INC
Company
Apnimed, Inc.
Company
Paysign, Inc.
Company
MARIMED INC.
Company
Nu-Med Plus, Inc.
Company
CARLSMED, INC.
Company
CervoMed Inc.
Company
PLDT Inc.
Company
PagerDuty, Inc.
Company
TUCOWS INC /PA/
Company
Pluri Inc.
Company
PETMED EXPRESS INC
Company
PACS Group, Inc.
Company
Electromed, Inc.
Company
Primary record6
PAVmed Inc. filed SCHEDULE 13G/A
0001094891-26-000317.txt : 20261103 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001094891-26-000174 0001839919 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 09/30/2026 0001624326 PAVmed Inc. 70387R5
PAVmed Inc. filed SCHEDULE 13G/A
0001094891-26-000308.txt : 20261023 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001094891-26-000162 0002101421 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 09/30/2026 0001624326 PAVmed Inc. 70387R5
PAVmed Inc. filed 8-K
Item 1.01. Entry into a Material Definitive Agreement. Effective as of October 21, 2026, Lucid Diagnostics Inc. (the “ Lucid Diagnostics ”), a subsidiary of PAVmed Inc. (the “ Company ”), entered into subscription agreem
PAVmed Inc. filed 8-K
Item 1.01. Entry Into a Material Definitive Agreement. On September 9, 2026, PAVmed Inc. (the “ Company ”) entered into a Sales Agreement (the “ Agreement ”) with A.G.P./Alliance Global Partners, as sales agent (the “ Ag
PAVmed Inc. filed 8-K
Item 2.02. Results of Operations and Financial Condition. On August 14, 2026, PAVmed Inc. (the “ Company ”) issued a press release announcing financial results for its fiscal quarter ended June 30, 2026 and providing a b
PAVmed Inc. filed SCHEDULE 13G/A
0001094891-26-000279.txt : 20260813 SCHEDULE 13G/A 1 primary_doc.xml X0202 SCHEDULE 13G/A 0001094891-26-000176 0000909440 XXXXXXXX LIVE 1 Common Stock, par value $0.001 per share 06/30/2026 0001624326 PAVmed Inc. 70387R5